SHANGHAI FOSUN PHARMACEUTICAL GROUP: IT AND HENAN GENUINE BIOTECH COOPERATE WITH MULTIPLE COMPANIES TO EXPAND PRODUCTION OF COVID TREATMENT AZVUDINE
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
23.67 CNY | -0.17% | +2.07% | -5.43% |
30/04 | Fosun Pharma's Q1 Profit Slumps 38% | MT |
29/04 | Shanghai Fosun Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.43% | 7.82B | |
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
+8.08% | 167B | |
-3.40% | 157B |
- Stock Market
- Equities
- 600196 Stock
- News Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
- Shanghai Fosun Pharmaceutical Group: It And Henan Genuine Biotec…